Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1651-1656

  Michelet, Christian ^a,b   Leib, Stephen L ^a   Bentue Ferrer, Daniele ^b   Täuber, Martin G ^a  

^a Institute for Medical Microbiology   (Switzerland)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; AMOXICILLIN; ANTIBIOTIC AGENT; COTRIMOXAZOLE; GENTAMICIN; SODIUM CHLORIDE; TROVAFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; HISTOPATHOLOGY; LISTERIA MONOCYTOGENES; MENINGOENCEPHALITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0345593757     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1651     Document Type: Article

References (31)

1. Cutler, N. R., J. Vincent, S. S. Jhee, R. Teng, T. Wardle, G. Lucas, L. C. Dogolo, and J. J. Sramek. 1997. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin. Antimicrob. Agents Chemother. 41:1298-1300.
2. Drevets, D. A., R. T. Sawyer, T. A. Potter, and P. A. Campbell. 1995. Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect. Immun. 63:4268-4276.
3. Facinelli, B., G. Magi, M. Prenna, S. Ripa, and P. E. Varaldo. 1997. In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones against Listeria monocytogenes. Eur. J. Clin. Microbiol. Infect. Dis. 16:827-833.
4. Gaillard, J. L., P. Berche, and P. Sansonetti. 1986. Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect. Immun. 52:50-55.
5. Goulet, V., and P. Marchetti. 1996. Listeriosis in 225 nonpregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions. Scand. J. Infect. Dis. 28:367-374.
6. Gray, M. L., and A. H. Killinger. 1966. Listeria monocytogenes and listeric infections. Bacteriol. Rev. 30:309-382.
7. Hof, H., and G. Waldenmeier. 1988. Therapy of experimental listeriosis - an evaluation of different antibiotics. Infection 16:S171-S174.
8. Jurado, R. L., M. M. Farley, E. Pereira, R. C. Harvey, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. Clin. Infect. Dis. 17:224-227.
9. Kim, Y. S., Q. Liu, L. L. Chow, and M. G. Täuber. 1997. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1186-1189.
10. Kim, Y. S., R. A. Sheldon, B. R. Elliott, Q. Liu, D. M. Ferriero, and M. G. Täuber. 1995. Brain injury in experimental neonatal meningitis due to group B streptococci. J. Neuropathol. Exp. Neurol. 54:531-539.
11. Leib, S. L., Y. S. Kim, L. L. Chow, R. A. Sheldon, and M. G. Täuber. 1996. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Investig. 98:2632-2639.
12. Lorber, B. 1997. Listeriosis. Clin. Infect. Dis. 24:1-11.
13. Luna, L. 1968. Manual of histologic staining methods of the AFIP, 3rd ed. McGraw-Hill Book Co., New York, N.Y.
14. Lutsar, I., I. R. Friedland, L. Wubbel, C. C. McCoig, H. S. Jafri, W. Ng, F. Ghaffar, and G. H. McCracken, Jr. 1998. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 42:2650-2655.
15. Marget, W., and H. P. R. Seeliger. 1988. Listeria monocytogenes infections: therapeutic possibilities and problems. Infection 16:S175-S177.
16. Metz, R., P. Muth, M. Ferger, W. Bolten, and H. Vergin. 1996. Improved determination of sulfadiazine in human plasma and urine by high-performance liquid performance chromatography. J. Chromatogr. 729:243-249.
17. Michelet, C., J.-L. Avril, F. Cartier, and P. Berche. 1994. Inhibition of intracellular growth of Listeria monocytogenes by antibiotics. Antimicrob. Agents Chemother. 38:438-446.
18. Michelet, C., J.-L. Avril, C. Arvieux, C. Jacquelinet, N. Vu, and F. Cartier. 1997. Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes. Antimicrob. Agents Chemother. 41:60-65.
19. Naii, R., T. Schmidt, K. Kaye, J. L. Froula, and M. G. Täuber. 1995. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 39:593-597.
20. Ostergaard, C., T. K. Sorensen, J. D. Knudsen, and N. Frimodt-Moller. 1998. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbit. Antimicrob. Agents Chemother. 42:1706-1712.
21. Rolston, K. V. I., D. H. Ho, B. LeBlanc, H. Streeter, and T. Dvorak. 1997. In vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer. J. Antimicrob. Chemother. 39(Suppl. B):15-22.
22. Scheid, W. M., D. D. Fletcher, F. N. Finck, and M. A. Sande. 1979. Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J. Infect. Dis. 140:287-294.
23. Schlech, W. F., P. M. Lavigne, R. A. Bortolussi, A. C. Allen, E. V. Haldane, A. J. Wort, A. W. Hightower, S. E. Johnson, S. H. King, E. S. Nicholls, and C. V. Broome. 1983. Epidemic listeriosis - evidence for transmission by food. N. Engl. J. Med. 308:203-206.
24. Schuchat, A., K. A. Deaver, J. D. Wenger, B. D. Plikaytis, L. Mascola, R. W. Pinner, A. L. Reingold, and C. V. Broome. 1992. Role of foods in sporadic listeriosis. Case control study of dietary risk factors. JAMA 267:2041-2045.
25. Schuchat, A., K. Robinson, J. D. Wengen, L. H. Harrisson, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337:970-976.
26. Skogberg, K., J. Syrjänen, M. Jahkola, O.-V. Renkonen, J. Paavonen, J. Ahonen, S. Kontiainen, P. Ruutu, and V. Valtonen. 1992. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin. Infect. Dis. 14:815-821.
27. Spitzer, P. G., S. M. Hammer, and A. W. Karchmer. 1986. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev. Infect. Dis. 8:427-430.
28. Tureen, J., Q. Liu, L. Chow, and M. G. Täuber. 1997. Comparison of trovafloxacin with other antibiotics for treatment of Listeria monocytogenes meningitis in the rabbit, abstr. B-80, p. 41. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
29. van der Steuijt, K., and P. Sonneveld. 1987. Concurrent analysis of methotrexate, trimethoprim, sulphamethoxazole and their major metabolites in plasma by high-performance liquid chromatography. J. Chromatogr. 422: 328-333.
30. Vincent, J., J. Venitz, R. Teng, B. A. Barris, S. A. Willavize, R. J. Plozer, and H. L. Friedman. 1997. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. J. Antimicrob. Chemother. 39(Suppl. B):385-394.
31. Winslow, D. L., and G. A. Pankey. 1982. In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes. Antimicrob. Agents Chemother. 22:51-54.